Patents
Patents for C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
05/1998
05/20/1998CN1182430A Carbohydrate conjugated bio-active compounds
05/19/1998US5753694 Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
04/1998
04/29/1998EP0783910A4 Process for the vacuum distillation of a liquid product, preferably crude petroleum, and a facility for carrying out the process
04/22/1998EP0764027A4 Method for protection against genotoxic mutagenesis
04/16/1998WO1998015544A1 Catalytic asymmetric epoxidation
04/16/1998WO1998015270A1 Anticonvulsant derivatives useful in treating neuropathic pain
04/16/1998CA2268255A1 Catalytic asymmetric epoxidation
04/15/1998EP0835118A2 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin
03/1998
03/31/1998US5734041 Preparation of chiral phosphorothioate oligomers
03/11/1998EP0827505A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
03/03/1998US5723589 Nonglycoside linkage
02/1998
02/26/1998WO1998007653A1 Chiral hydride complexes
02/12/1998WO1998000130A3 Anticonvulsant sulfamate derivatives useful in treating obesity
02/12/1998WO1998000129A3 Anticonvulsant derivatives useful in treating psoriasis
02/03/1998US5714599 Process for the preparation of ste specific 1'-spiro-nucleosides
01/1998
01/08/1998WO1998000131A1 Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als)
01/08/1998WO1998000130A2 Anticonvulsant sulfamate derivatives useful in treating obesity
01/08/1998WO1998000129A2 Anticonvulsant derivatives useful in treating psoriasis
12/1997
12/10/1997EP0811011A1 Carbohydrate conjugated bio-active compounds
12/02/1997US5693799 Phosphinates having a reactive p-h bond and a protected p-h bond can be reacted with an organic group selected from aldehyde, ketone, or a sugar having ethylenic group reactive to p-h to give product, hydrolysis to remove protected group
11/1997
11/20/1997WO1997043295A1 D-pentofuranose derivatives and process for the preparation thereof
11/18/1997US5688971 Plant growth regulators, herbicides
11/11/1997US5686444 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/04/1997US5683963 Herbicidal ribofuranose derivatives
10/1997
10/29/1997CN1163270A Anti-hyerplasia and anti-inflammatory compound: pentose monosaccharide devivative
10/21/1997US5679459 Perfluorinated amphiphilic phosphorous compounds: liposomal compositions
10/07/1997US5674867 Administering the drug for treating thrombocytopenia, blood disorders
09/1997
09/24/1997CN1035923C Method for preparing lipophilic oligosaccharide antibiotics composition
09/17/1997EP0733056A4 Glycozylhydrazines, preparation, immobilization and reactions of: glycoprotein analysis and o-glycan removal
09/10/1997CN1035820C Improved process for preparation of sulfamate derivatives
08/1997
08/19/1997US5659015 For enhancing serum lifetime of protein conjugates; enhancing drug delivery
07/1997
07/31/1997WO1997027205A1 Imidazo[1,2-a]pyridine c-nucleosides as antiviral agents
07/31/1997WO1997027204A1 Modified benzimidazole nucleosides as antiviral agents
07/31/1997CA2244378A1 Modified benzimidazole nucleosides as antiviral agents
07/30/1997EP0668866B1 Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
07/22/1997US5650407 Selected soluble esters of hydroxyl-containing indolocarbazoles
07/16/1997EP0783910A1 Process for the vacuum distillation of a liquid product, preferably crude petroleum, and a facility for carrying out the process
07/03/1997WO1997023494A1 Carbohydrate conjugated bio-active compounds
07/03/1997CA2213489A1 Carbohydrate conjugated bio-active compounds
06/1997
06/24/1997US5641882 Intermediates for the preparation of 1',1'-disubstituted and 1'-spiro-nucleosides
06/18/1997EP0778843A1 Intermediates for dinucleotide and oligonucleotide analogues
06/05/1997WO1997019950A1 Topiramate immunoassay, as well as analogs and antibodies
05/1997
05/22/1997WO1997018223A1 Improved method and agents for inhibiting protein aging
05/22/1997WO1997018222A2 Novel oligosaccharide glycosides having mammalian immunosuppressive and tolerogenic properties
05/22/1997CA2237565A1 Improved method and agents for inhibiting protein aging
05/15/1997WO1997017071A1 Stereoselective synthesis of endothelin receptor antagonists
05/15/1997CA2236924A1 Stereoselective synthesis of endothelin receptor antagonists
05/14/1997CN1034866C Method for solvent-free synthesis of etherally substituted blocked monosaccharides
05/06/1997US5627272 Process for preparing sugar acetonides
04/1997
04/29/1997US5624914 Everninomycins, cyclodextran derivative, nonionic surfactant
04/24/1997WO1997014710A1 Preparation of phosphorothioate oligomers
04/16/1997EP0767657A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
04/15/1997US5621084 Process for removal of allyl group or allyloxycarbonyl group
03/1997
03/26/1997EP0764027A1 Method for protection against genotoxic mutagenesis
03/19/1997EP0763042A1 Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents
03/19/1997EP0763041A1 Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
03/19/1997EP0763040A1 Carbazole derivatives as agents against multi-drug resistance
03/13/1997WO1997001343A3 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin
03/12/1997CN1034217C Anti-proliferative and anti-inflammatory compounds:derivatives of pentose monosaccharides
02/1997
02/18/1997US5604219 Indolocarbazole derivatives that stimulate platelet production
02/11/1997US5602262 Process for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
01/1997
01/23/1997WO1997002034A1 Anti-infection, anti-inflammatory and anti-tumour drug
01/21/1997US5595976 Tetrahydropyran compounds
01/16/1997WO1997001343A2 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin
01/16/1997CA2222273A1 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin
12/1996
12/31/1996US5589366 Process for producing antiparasitic macrolide antibiotics
12/12/1996WO1996039444A1 Production of fructose dianhydride products and derivatives from inulin
11/1996
11/12/1996US5573946 Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds
10/1996
10/22/1996US5567686 Method for protection against genotoxic mutagenesis
10/15/1996US5565037 Process for preparing 1,2-5,6-diacetone-D-glucose
10/10/1996WO1996031515A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
10/10/1996CA2215111A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
09/1996
09/25/1996EP0733056A1 Glycozylhydrazines, preparation, immobilization and reactions of: glycoprotein analysis and o-glycan removal
08/1996
08/21/1996EP0727432A1 Process for the preparation of 2-deoxy-2,2-difluoro-beta-d-ribo-pentopyranose
08/04/1996CA2167895A1 Process for the preparation of 1-(2'-deoxy-2',2'-difluoro-d-ribopentofuranosyl) -cytosine from 2-deoxy-2, 2-difluoro-beta-d-ribo-pentopyranose
07/1996
07/31/1996CN1127757A New tetrahydropyran compounds, process for the preparation thereof, and pharmaceutical compositions containing them
06/1996
06/06/1996WO1995029927A3 Process for preparation of glycosides of tumor-associated carbohydrate antigens
04/1996
04/23/1996US5510372 For treating or preventing insect or worm infestations in animals
04/16/1996US5508270 Nucleoside phosphinate compounds and compositions
03/1996
03/21/1996WO1996008503A1 Intermediates for dinucleotide and oligonucleotide analogues
03/21/1996CA2198900A1 Intermediates for dinucleotide and oligonucleotide analogues
03/06/1996EP0699679A1 Tetrahydropyranyl compounds, process for their preparation and pharmaceutical compositions containing them
03/01/1996CA2157156A1 New tetrahydropyranic compounds, process for their preparation and pharmaceutical composition containing them
02/1996
02/29/1996WO1996005900A1 Process for the vacuum distillation of a liquid product, preferably crude petroleum, and a facility for carrying out the process
02/14/1996EP0696598A1 Polysaccharide esters and their salts
01/1996
01/30/1996US5488171 Intermediates for nucleotide analogs with viricide properties
01/30/1996US5488042 Method for protection against genotoxic mutagenesis
12/1995
12/28/1995WO1995035102A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
12/28/1995CA2192950A1 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
12/07/1995WO1995032976A1 Polycyclic lactam derivatives for sensitizing multidrug-resistant cells to antitumour agents
12/07/1995WO1995032975A1 Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents
12/07/1995WO1995032974A1 Carbazole derivatives as agents against multi-drug resistance
11/1995
11/09/1995WO1995029927A2 Process for preparation of glycosides of tumor-associated carbohydrate antigens
11/09/1995CA2189356A1 Process for preparation of glycosides of tumor-associated carbohydrate antigens
10/1995
10/11/1995EP0676236A1 Process for removal of allyl group or allyloxycarbonyl group
10/11/1995EP0675893A1 Anticonvulsant sorbopyranose sulfamates
09/1995
09/27/1995EP0673947A1 Psicofuranose and psicopyranose derivatives
09/20/1995EP0672668A1 Indolocarbazole derivatives and their use in the treatment of thrombocytopenia
09/19/1995CA2144941A1 Indolocarbazole derivatives
09/12/1995US5449772 Continuous process for the preparation of sucrose 6-esters
1 2 3 4 5 6 7 8 9 10 11 12